BioElectronics receives product approvals
This article was originally published in The Tan Sheet
Executive Summary
Health Canada approves BioElectronics Corp.'s Allay Menstrual Pain Therapy product for OTC sale to treat menstrual pain symptoms. The Frederick, Md.-based company also announces June 29 that South Korea's regulators approved its ActiPatch for reducing muscle pain. "With its proven technology and established clinical platform, Allay and ActiPatch are very unique brands in both Canada and Korea," the company said. BioElectronics noted the approvals open doors into new markets. The firm's pain relief products already are available in 44 countries worldwide